Proteinuria-associated endothelial dysfunction is strain dependent

American Journal of Nephrology

Volumn 30, Issue 3, 2009, Pages 209-217

  Ulu, Nadir ^a,d   Schoemaker, Regien G ^b,d   Henning, Robert H ^a,d   Buikema, Hendrik ^a,d   Teerlink, Tom ^e   Zijlstra, Freek J ^f   Bakker, Stephan J L ^c,d   Van Gilst, Wiek H ^b,d   Navis, Gerjan ^c,d  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Department of Experimental Cardiology ^*

^c Divisions of Nephrology Dialysis and Transplantation   (United States)

^d UNIVERSITY OF GRONINGEN   (Netherlands)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^f ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Endothelial dysfunction; Kidney disease; Proteinuria

Indexed keywords

ARGININE; PROSTAGLANDIN E2; PROSTAGLANDIN F1 ALPHA; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN SYNTHASE; THROMBOXANE B2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FAWN HOODED HYPERTENSIVE RAT; HEART FUNCTION; KIDNEY DISEASE; LEWIS RAT; LIPID BLOOD LEVEL; MALE; MONICH WISTAR FROMTER RAT; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN BLOOD LEVEL; PROTEINURIA; RAT; RAT STRAIN; RISK FACTOR;

ANIMALS; ENDOTHELIUM, VASCULAR; MALE; PROTEINURIA; RATS; RATS, INBRED LEW; RATS, INBRED STRAINS;

EID: 65449146396     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000218062     Document Type: Article

References (38)

1. Henry RM, Kostense PJ, Bos G, Dekker JM, Nijpels G, Heine RJ, et al: Mild renal insufficiency is associated with increased cardiovascular mortality: the Hoorn Study. Kidney Int 2002; 62: 1402-1407.
2. Hillege HL, Janssen WM, Bak AA, Diercks GF, Grobbee DE, Crijns HJ, et al: Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J Intern Med 2001; 249: 519-526.
3. Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, van Veldhuisen DJ, et al: Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in the general population. Circulation 2002; 106: 1777-1782.
4. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, et al: Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004; 351: 1285-1295.
5. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305.
6. Arnlov J, Evans JC, Meigs JB, Wang TJ, Fox CS, Levy D, et al: Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation 2005; 112: 969-975.
7. Raine AE, Seymour AM, Roberts AF, Radda GK, Ledingham JG: Impairment of cardiac function and energetics in experimental renal failure. J Clin Invest 1993; 92: 2934-2940.
8. Amann K, Tyralla K, Gross ML, Schwarz U, Törnig J, Haas CS, et al: Cardiomyocyte loss in experimental renal failure: prevention by ramipril. Kidney Int 2003; 63: 1708-1713.
9. Mahmoodi BK, ten Kate MK, Waanders F, Veeger NJ, Brouwer JL, Vogt L, et al: High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study. Circulation 2008; 117: 224-230.
10. Mui KW, Sleeswijk M, van den Hout H, van Baal J, Navis G, Woittiez AJ et al: Incidental renal artery stenosis is an independent predictor of mortality in patients with peripheral vascular disease. J Am Soc Nephrol 2006; 17: 2069-2074.
11. Bongartz LG, Cramer MJ, Doevendans PA, Joles JA, Braam B: The severe cardiorenal syndrome: 'Guyton revisited'. Eur Heart J 2005; 26: 11-17.
12. Stam F, van Guldener C, Becker A, Dekker JM, Heine RJ, Bouter LM, Stehouwer CD: Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study. J Am Soc Nephrol 2006; 17: 537-545.
13. Stroes ES, Joles JA, Chang PC, Koomans HA, Rabelink TJ: Impaired endothelial function in patients with nephrotic range proteinuria. Kidney Int 1995; 48: 544-550.
14. Ito M, Oguri M, Naruse A, Ito H, Suzuki Y, Satake N, Shibata S: Impaired endotheliumdependent relaxation in isolated thoracic aorta of rats with daunomycin-induced nephrosis. J Pharmacol Exp Ther 1991; 258: 388-395.
15. Ulu N, Buikema H, van Gilst WH, Navis G: Vascular dysfunction in adriamycin nephrosis: different effects of adriamycin exposure and nephrosis. Nephrol Dial Transplant 2008; 23: 1854-1860.
16. Langendorff O: Untersuchungen am überlebenden Säugetierherzen. Pflügers Arch 1895; 61: 291-332.
17. Voors AA, Pinto YM, Buikema H, Urata H, Oosterga M, Rooks G, et al: Dual pathway for angiotensin II formation in human internal mammary arteries. Br J Pharmacol 1998; 125: 1028-1032.
18. Zijlstra FJ, Vincent JE, Mol WM, Hoogsteden HC, Van Hal PT, Jongejan RC: Eicosanoid levels in bronchoalveolar lavage fluid of young female smokers and non-smokers. Eur J Clin Invest 1992; 22: 301-306.
19. Teerlink T, Nijveldt RJ, de Jong S, van Leeuwen PA: Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography. Anal Biochem 2002; 303: 131-137.
20. De Jong S, Teerlink T: Analysis of asymmetric dimethylarginine in plasma by HPLC using a monolithic column. Anal Biochem 2006; 353: 287-289.
21. Behrendt D, Ganz P: Endothelial function: from vascular biology to clinical applications. Am J Cardiol 2002; 90: 40L-48L.
22. Teerlink JR, Clozel M, Fischli W, Clozel JP: Temporal evolution of endothelial dysfunction in a rat model of chronic heart failure. J Am Coll Cardiol 1993; 22: 615-620.
23. Ulu N, Henning RH, Goris M, Schoemaker RG, van Gilst WH: Effects of ivabradine and metoprolol on cardiac angiogenesis and endothelial dysfunction in rats with heart failure. J Cardiovasc Pharmacol 2009; 53: 9-17.
24. Xiao S, Wagner L, Schmidt RJ, Baylis C: Circulating endothelial nitric oxide synthase inhibitory factor in some patients with chronic renal disease. Kidney Int 2001; 59: 1466-1472.
25. Wang D, Iversen J, Strandgaard S: Endothelium- dependent relaxation of small resistance vessels is impaired in patients with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 2000; 11: 1371-1376.
26. Yilmaz MI, Sonmez A, Saglam M, Qureshi AR, Carrero JJ, Caglar K, et al: ADMA levels correlate with proteinuria, secondary amyloidosis, and endothelial dysfunction. J Am Soc Nephrol 2008; 19: 388-395.
27. Dai FX, Skopec J, Diederich A, Diederich D: Prostaglandin H2 and thromboxane A2 are contractile factors in intrarenal arteries of spontaneously hypertensive rats. Hypertension 1992; 19: 795-798.
28. Iwama Y, Kato T, Muramatsu M, Asano H, Shimizu K, Toki Y, et al: Correlation with blood pressure of the acetylcholine-induced endothelium-derived contracting factor in the rat aorta. Hypertension 1992; 19: 326-332.
29. Blanco-Rivero J, Cachofeiro V, Lahera V, Aras-Lopez R, Márquez-Rodas I, Salaices M, et al: Participation of prostacyclin in endothelial dysfunction nduced by aldosterone in normotensive and hypertensive rats. Hypertension 2005; 46: 29-30.
30. Ordonez JD, Hiatt RA, Killebrew EJ, Fireman BH: The increased risk of coronary heart disease associated with the nephrotic syndrome. Kidney Int 1993; 44: 638-642.
31. Paisley KE, Beaman M, Tooke JE, Mohamed- Ali V, Lowe GD, Shore AC: Endothelial dysfunction in asymptomatic proteinuria. Kidney Int 2003; 63: 624-633.
32. Remuzzi G, Ruggenenti P, Perico N: Chronic renal diseases: renoprotective benefits of renin- angiotensin system inhibition. Ann Intern Med 2002; 134: 604-615.
33. Keane WF, Kasiske BL: Hyperlipidemia in the nephrotic syndrome. N Engl J Med 1990; 323: 603-604.
34. Ijpelaar DH, Schulz A, Koop K, Schlesener M, Bruijn JA, Kerjaschki D, et al: Glomerular hypertrophy precedes albuminuria and segmental loss of podoplanin in podocytes in Munich-Wistar-Frömter rats. Am J Physiol Renal Physiol 2008; 294:F758-F767.
35. Kuijpers MH, de Jong W: Relationship between blood pressure level, renal histopathological lesions and plasma renin activity in fawn-hooded rats. Br J Exp Pathol 1987; 68: 179-187.
36. Remuzzi A, Gagliardini E, Donadoni C, Fassi A, Sangalli F, Lepre MS, et al: Effect of angiotensin II antagonism on the regression of kidney disease in the rat. Kidney Int 2002; 62: 885-894.
37. Gschwend S, Pinto-Sietsma SJ, Buikema H, Pinto YM, van Gilst WH, Schulz A, et al: Impaired coronary endothelial function in a rat model of spontaneous albuminuria. Kidney Int 2002; 62: 181-191.
38. Wang D, Gill PS, Chabrashvili T, Onozato ML, Raggio J, Mendonca M, Dennehy K, Li M, Modlinger P, Leiper J, Vallance P, Adler O, Leone A, Tojo A, Welch WJ, Wilcox CS: Isoform-specific regulation by N(G),N(G)- dimethylarginine dimethylaminohydrolase of rat serum asymmetric dimethylarginine and vascular endothelium-derived relaxing factor/NO. Circ Res 2007; 101: 627-635.